"3"^^ . . "4" . "F\u00EDnek, Jind\u0159ich" . . "[ACB7839713E3]" . "Sk\u00E1lov\u00E1, Alena" . . "Karcinom prsu je chronick\u00E9 onemocn\u011Bn\u00ED s dlouhodob\u00FDm mnohalet\u00FDm pr\u016Fb\u011Bhem. Nejnov\u011Bj\u0161\u00ED epidemiologick\u00E1 data N\u00E1rodn\u00EDho onkologick\u00E9ho registru (NOR) potvrzuj\u00ED fakt, \u017Ee karcinom prsu je v \u010Cesk\u00E9 republice nej\u010Dast\u011Bj\u0161\u00EDm zhoubn\u00FDm onemocn\u011Bn\u00EDm \u017Een a jeho incidence trvale v\u00FDrazn\u011B roste.(1) Posledn\u00ED data z NOR jsou z roku 2010, kdy bylo hl\u00E1\u0161eno 6 498 nov\u00FDch n\u00E1dor\u016F prsu u \u017Een. Pr\u016Fm\u011Brn\u00FD v\u011Bk pacientek s karcinomem prsu v dob\u011B diagn\u00F3zy je 62,8 let; v\u00EDce ne\u017E 80 % pacientek onemocn\u00ED v 5.-7. deceniu. Na \u0159ad\u011B onkologick\u00FDch pracovi\u0161\u0165 je pozorov\u00E1n spolu se zvy\u0161uj\u00EDc\u00EDm se po\u010Dtem nemocn\u00FDch s karcinomem prsu i \u010Detn\u011Bj\u0161\u00ED z\u00E1chyt onemocn\u011Bn\u00ED ve skupin\u011B mlad\u00FDch \u017Een (ve v\u011Bku 35 let a m\u00E9n\u011B). Zdali se incidence zhoubn\u00FDch n\u00E1dor\u016F prsu v populaci mlad\u00FDch \u017Een v \u010CR skute\u010Dn\u011B zvy\u0161uje, nebylo dosud dolo\u017Eeno s jistotou.(1) Incidence karcinomu prsu u mlad\u00FDch \u017Een je sice relativn\u011B n\u00EDzk\u00E1, podle statistik reprezentuje m\u00E9n\u011B ne\u017E 2 % nemocn\u00FDch, ale d\u016Fsledky t\u00E9to nemoci jsou v t\u00E9to v\u011Bkov\u00E9 kategorii v\u00FDznamn\u00E9. Pr\u016Fb\u011Bh onemocn\u011Bn\u00ED je podstatn\u011B rychlej\u0161\u00ED a z\u00E1va\u017En\u011Bj\u0161\u00ED ne\u017E u star\u0161\u00EDch \u017Een.(2) Uv\u00E1d\u00ED se, \u017Ee a\u017E 65 % pacientek m\u00E1 axil\u00E1rn\u00ED metast\u00E1zu v dob\u011B diagn\u00F3zy. Tak\u00E9 je vy\u0161\u0161\u00ED pod\u00EDl pacientek s primo-diagn\u00F3zou v pozd\u011Bj\u0161\u00EDch stadi\u00EDch (III a IV) ne\u017E u \u017Een star\u0161\u00EDch. Zaznamen\u00E1ny jsou t\u00E9\u017E \u010Dast\u011Bj\u0161\u00ED recidivy po konzervativn\u00ED terapii. Z\u010D\u00E1sti m\u016F\u017Ee nep\u0159\u00EDzniv\u00E1 progn\u00F3za j\u00EDt na vrub pozdn\u00EDho odhalen\u00ED karcinomu, kdy se karcinom u mlad\u00FDch \u017Een nep\u0159edpokl\u00E1d\u00E1, ale obecn\u011B nejsou d\u016Fvody t\u00E9to v\u011Bkov\u00E9 z\u00E1vislosti p\u0159esn\u011B ve v\u0161ech aspektech vysv\u011Btlen\u00E9 a vych\u00E1zej\u00ED zcela z\u0159ejm\u011B z biologick\u00E9 povahy n\u00E1dor\u016F." . . "Breast Cancer News" . . . . "Breast cancer of young women- serious medical problem"@en . "Young women with breast cancer have a poorer prognosis than older women."@en . . "CZ - \u010Cesk\u00E1 republika" . . "Breast cancer of young women- serious medical problem"@en . "RIV/00216208:11140/14:10189160!RIV15-MSM-11140___" . "Karcinom prsu u mlad\u00FDch \u017Een - z\u00E1va\u017En\u00FD medic\u00EDnsk\u00FD probl\u00E9m"@cs . "1804-8218" . "11140" . "1" . . . . . "Karcinom prsu u mlad\u00FDch \u017Een - z\u00E1va\u017En\u00FD medic\u00EDnsk\u00FD probl\u00E9m" . . "Karcinom prsu je chronick\u00E9 onemocn\u011Bn\u00ED s dlouhodob\u00FDm mnohalet\u00FDm pr\u016Fb\u011Bhem. Nejnov\u011Bj\u0161\u00ED epidemiologick\u00E1 data N\u00E1rodn\u00EDho onkologick\u00E9ho registru (NOR) potvrzuj\u00ED fakt, \u017Ee karcinom prsu je v \u010Cesk\u00E9 republice nej\u010Dast\u011Bj\u0161\u00EDm zhoubn\u00FDm onemocn\u011Bn\u00EDm \u017Een a jeho incidence trvale v\u00FDrazn\u011B roste.(1) Posledn\u00ED data z NOR jsou z roku 2010, kdy bylo hl\u00E1\u0161eno 6 498 nov\u00FDch n\u00E1dor\u016F prsu u \u017Een. Pr\u016Fm\u011Brn\u00FD v\u011Bk pacientek s karcinomem prsu v dob\u011B diagn\u00F3zy je 62,8 let; v\u00EDce ne\u017E 80 % pacientek onemocn\u00ED v 5.-7. deceniu. Na \u0159ad\u011B onkologick\u00FDch pracovi\u0161\u0165 je pozorov\u00E1n spolu se zvy\u0161uj\u00EDc\u00EDm se po\u010Dtem nemocn\u00FDch s karcinomem prsu i \u010Detn\u011Bj\u0161\u00ED z\u00E1chyt onemocn\u011Bn\u00ED ve skupin\u011B mlad\u00FDch \u017Een (ve v\u011Bku 35 let a m\u00E9n\u011B). Zdali se incidence zhoubn\u00FDch n\u00E1dor\u016F prsu v populaci mlad\u00FDch \u017Een v \u010CR skute\u010Dn\u011B zvy\u0161uje, nebylo dosud dolo\u017Eeno s jistotou.(1) Incidence karcinomu prsu u mlad\u00FDch \u017Een je sice relativn\u011B n\u00EDzk\u00E1, podle statistik reprezentuje m\u00E9n\u011B ne\u017E 2 % nemocn\u00FDch, ale d\u016Fsledky t\u00E9to nemoci jsou v t\u00E9to v\u011Bkov\u00E9 kategorii v\u00FDznamn\u00E9. Pr\u016Fb\u011Bh onemocn\u011Bn\u00ED je podstatn\u011B rychlej\u0161\u00ED a z\u00E1va\u017En\u011Bj\u0161\u00ED ne\u017E u star\u0161\u00EDch \u017Een.(2) Uv\u00E1d\u00ED se, \u017Ee a\u017E 65 % pacientek m\u00E1 axil\u00E1rn\u00ED metast\u00E1zu v dob\u011B diagn\u00F3zy. Tak\u00E9 je vy\u0161\u0161\u00ED pod\u00EDl pacientek s primo-diagn\u00F3zou v pozd\u011Bj\u0161\u00EDch stadi\u00EDch (III a IV) ne\u017E u \u017Een star\u0161\u00EDch. Zaznamen\u00E1ny jsou t\u00E9\u017E \u010Dast\u011Bj\u0161\u00ED recidivy po konzervativn\u00ED terapii. Z\u010D\u00E1sti m\u016F\u017Ee nep\u0159\u00EDzniv\u00E1 progn\u00F3za j\u00EDt na vrub pozdn\u00EDho odhalen\u00ED karcinomu, kdy se karcinom u mlad\u00FDch \u017Een nep\u0159edpokl\u00E1d\u00E1, ale obecn\u011B nejsou d\u016Fvody t\u00E9to v\u011Bkov\u00E9 z\u00E1vislosti p\u0159esn\u011B ve v\u0161ech aspektech vysv\u011Btlen\u00E9 a vych\u00E1zej\u00ED zcela z\u0159ejm\u011B z biologick\u00E9 povahy n\u00E1dor\u016F."@cs . . "23991" . . "I" . "Karcinom prsu u mlad\u00FDch \u017Een - z\u00E1va\u017En\u00FD medic\u00EDnsk\u00FD probl\u00E9m"@cs . "3"^^ . "prognosis; triple negative; hereditary cancer; young women; breast cancer"@en . "RIV/00216208:11140/14:10189160" . . "3"^^ . . "Karcinom prsu u mlad\u00FDch \u017Een - z\u00E1va\u017En\u00FD medic\u00EDnsk\u00FD probl\u00E9m" .